Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Clinical trial NCT06825559 · RECRUITING
Trial details
- NCT number
- NCT06825559
- Sponsor
- Zydus Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-05
- Primary completion
- 2026-07-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.